Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $28.01. The company's market cap stands at 159.94B, with a P/E ratio of 40.72 and a dividend yield of 6.04%.
On 2026-11-19, Pfizer(PFE) stock moved within a range of $28.00 to $28.54. With shares now at $28.01, the stock is trading +0.0% above its intraday low and -1.8% below the session's peak.
Trading activity shows a volume of 37.66M, compared to an average daily volume of 36.98M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.44 and a low of $23.62.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.44 and a low of $23.62.
PFE News
H.C. Wainwright reiterates a Buy rating on Legend Biotech (LEGN) with a $65 price target after Pfizer (PFE) announced an agreement to license three in vivo CAR-...
Pfizer Inc. (NYSE:PFE) announced Wednesday an exclusive licensing agreement with Starna Therapeutics worth up to $2.63 billion in upfront and milestone payments...
Pfizer (PFE) on Wednesday announced an exclusive licensing agreement with China-based RNA medicines company Starna Therapeutics to develop and commercialize chi...
Analyst ratings
63%
of 27 ratingsMore PFE News
Pfizer (PFE) announced that it entered into an exclusive licensing agreement with Starna Therapeutics, a biotechnology company developing RNA medicines designed...
Pfizer (NYSE:PFE) agreed to acquire obesity drug developer Metsera for about US$10b in cash, expanding its metabolic disease portfolio. The deal strengthens Pf...
It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...
Johnson & Johnson: Steady Upward Recent Revenue Growth Johnson & Johnson (JNJ -0.97%) primarily generates revenue by developing and selling pharmaceutical and m...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer’s study, officially titled “KOREAN POST-MARKETING SURVEILLANCE FOR...
Pfizer (PFE) just secured up to US$1.5b in external funding from Blackstone Life Sciences for berobenatide, its investigational monthly GLP 1 obesity drug, whil...
As the global health landscape shifts toward obesity treatments, investors are weighing the rapid growth of Novo Nordisk A/S (NVO +2.41%) against the deep-roote...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.